|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported that the patient experienced bradycardia.Upon device assessment it was noted that the right atrial (ra) lead exhibited far field r-wave (ffrw) oversensing, triggering atrial tachycardia (at)/atrial fibrillation (af) detections.Reports of heart rates in the twenties were reported, with possible non-capture on the right ventricular (rv) lead.The implantable pulse generator (ipg) system remains in use.No further patient complications have been reported as a result of this event.
|